JURNAL AGROINDUSTRI HALAL,
Год журнала:
2023,
Номер
9(2), С. 130 - 139
Опубликована: Авг. 31, 2023
Herbal
rice
made
from
white
by
adding
a
mixture
of
turmeric,
cinnamon
and
guava
leaves
during
cooking,
reducing
cholesterol
levels
in
hypercholesterolemia.
This
study
was
aims
to
evaluate
the
protein
digestibility
efficiency
ratio
herbal
rats
given
high
fat
diet.
used
28
male
Spangue
dawley
aged
12
weeks
divided
into
four
treatment
groups
(7
per
group).
The
control
group
(P0)
standard
diet
AIN-76
without
induction,
(P1)
containing
plain
flour
with
(P2)
cooked
1
bag
mixed
herbs
(P3)
2
bags
induction.
results
showed
that
body
weight
each
rat
increased
days
experiment.
type
ration
had
significant
effect
(p<0.05)
on
value
digestibility,
but
no
(PER).
Result
evaluation
weight,
PER
obtained,
it
can
be
concluded
has
better
quality
than
rice.
Complementary Therapies in Medicine,
Год журнала:
2024,
Номер
80, С. 103025 - 103025
Опубликована: Янв. 16, 2024
Curcumin
has
antioxidant
properties
and
been
proposed
as
a
potential
treatment
for
NAFLD.
The
aim
of
current
systematic
review
meta-analysis
was
to
evaluate
previous
findings
the
effect
curcumin
supplementation
on
glycaemic
indices,
lipid
profile,
blood
pressure,
inflammatory
markers,
anthropometric
measurements
NAFLD
patients.
Relevant
studies
published
up
January
2024
were
searched
systematically
using
following
databases:
PubMed,
SCOPUS,
WOS,
Science
Direct,
Ovid
Cochrane.
conducted
according
2020
PRISMA
guidelines.
quality
papers
assessed
Joanna
Briggs
Institute
(JBI)
Critical
Appraisal
Checklist.
Pooled
sizes
calculated
random-effects
model
reported
WMD
95%
CI.
Also,
subgroup
analyses
done
find
probable
sources
heterogeneity
among
studies.
Out
21010
records
initially
identified,
21
eligible
RCTs
selected
inclusion
in
meta-analysis.
Overall,
1191
participants
both
genders,
600
intervention
591
control
group
with
included.
There
are
several
limitations
that
included,
instance,
results
weakened
substantially
by
bias
or
failure
account
adulteration
(with
pharmaceuticals)
contamination
other
herbs)
supplements
tested.
However,
have
be
safe
complementary
therapy
conditions.
Our
study
indicated
doses
50−3000
mg/day
associated
significant
change
FBG
[WMD:
−2.83;
CI:
−4.61,
−1.06),
I2
=
51.3%],
HOMA-IR
−0.52;
−0.84,
−0.20),
I2=
82.8%],
TG
−10.31;
−20.00,
−0.61),
84.5%],
TC
−11.81;
−19.65,
−3.96),
94.6%],
LDL
−8.01;
−15.79,
−0.24),
96.1%],
weight
−0.81;
−1.28,
−0.35),
0.0%]
BMI
−0.35;
−0.57,
−0.13),
adults
no
HbA1C,
plasma
insulin,
QUICKI,
HDL,
SBP,
DBP,
CRP,
TNF-α
WC
after
therapy.
Subgroup
analysis
suggested
changes
serum
FBG,
TG,
durations
≥
8
weeks,
LDL,
BMI,
sample
size
>
55
participants.
over
8–12
weeks
reductions
levels
HOMA-IR,
TC,
patients
Previous
diseases.
We
would
suggest
should
used
clinically
specific
conditions,
it
caution.
difference
grades
may
evaluated
outcomes,
so
is
future
an
subgroups
their
grade.
Furthermore,
because
conduct
independent
biochemical
assessment
turmeric/curcumin
product
most
well
bias,
interpreted
Pharmaceutics,
Год журнала:
2023,
Номер
15(4), С. 1275 - 1275
Опубликована: Апрель 19, 2023
Although
the
anticancer
role
of
curcumin
has
been
extensively
addressed
in
preclinical
research,
only
a
few
studies
were
carried
out
humans,
with
conflicting
results.
The
aim
this
systematic
review
is
to
collate
together
results
therapeutic
effect
cancer
patients.
A
literature
search
was
Pubmed,
Scopus,
and
Cochrane
Central
Register
Controlled
Trials
up
29
January
2023.
Only
randomized
controlled
trials
(RCTs)
designed
evaluate
effects
on
progression,
patient
survival,
or
surgical/histological
response
included.
Seven
114
articles,
published
between
2016
2022,
analyzed.
They
evaluated
patients
locally
advanced
and/or
metastatic
prostate,
colorectal,
breast
cancers,
as
well
multiple
myeloma
oral
leucoplakia.
Curcumin
given
an
add-on
therapy
five
studies.
Cancer
most
investigated
primary
endpoint
issued
some
positive
On
contrary,
ineffective
improving
overall
progression-free
survival.
safety
profile
favorable.
In
conclusion,
available
clinical
evidence
not
strong
enough
support
use
cancer.
New
RCTs
exploring
different
formulations
early-stage
cancers
would
be
welcome.
Antioxidants,
Год журнала:
2023,
Номер
12(6), С. 1163 - 1163
Опубликована: Май 27, 2023
Mitochondrial
fission
is
a
crucial
process
in
maintaining
metabolic
homeostasis
normal
physiology
and
under
conditions
of
stress.
Its
dysregulation
has
been
associated
with
several
diseases,
including,
but
not
limited
to,
obesity,
type
2
diabetes
(T2DM),
cardiovascular
diseases.
Reactive
oxygen
species
(ROS)
serve
vital
role
the
genesis
these
conditions,
mitochondria
are
both
main
sites
ROS
production
primary
targets
ROS.
In
this
review,
we
explore
physiological
pathological
roles
mitochondrial
fission,
its
regulation
by
dynamin-related
protein
1
(Drp1),
interplay
between
health
We
also
discuss
potential
therapeutic
strategies
targeting
through
antioxidant
treatments
for
ROS-induced
including
effects
lifestyle
interventions,
dietary
supplements,
chemicals,
such
as
division
inhibitor-1
(Mdivi-1)
other
inhibitors,
well
certain
commonly
used
drugs
This
review
highlights
importance
understanding
approach
to
protecting
against
conditions.
Nutrients,
Год журнала:
2023,
Номер
15(2), С. 411 - 411
Опубликована: Янв. 13, 2023
Nutraceuticals
act
as
cellular
and
functional
modulators,
contributing
to
the
homeostasis
of
physiological
processes.
In
an
inflammatory
microenvironment,
these
foods
can
interact
with
immune
system
by
modulating
or
balancing
exacerbated
proinflammatory
response.
this
process,
cells,
such
antigen-presenting
cells
(APCs),
identify
danger
signals
and,
after
interacting
T
lymphocytes,
induce
a
specific
effector
Moreover,
conditions
their
change
state
phenotypical
modifications
from
resting
activated
state,
supposing
increase
in
energy
requirements
that
affect
intracellular
metabolism,
each
cell
showing
unique
metabolic
signature.
Thus,
nutraceuticals,
polyphenols,
vitamins,
fatty
acids,
sulforaphane,
represent
active
option
use
therapeutically
for
health
prevention
different
pathologies,
including
obesity,
syndrome,
diabetes.
To
regulate
inflammation
associated
intervention
pathways
through
modulation
nutraceuticals
is
attractive
strategy
allows
inducing
important
changes
properties.
we
provide
overview
link
between
function,
chronic
processes
obesity
diabetes,
paying
particular
attention
nutritional
effects
on
APC
immunometabolism,
well
mechanisms
required
energetic
involved
activation.
Pharmacological Research,
Год журнала:
2022,
Номер
187, С. 106599 - 106599
Опубликована: Дек. 9, 2022
Obesity
represents
the
most
frequent
chronic
disease
among
children
worldwide,
with
a
significant
global
burden
on
society.
Metabolically
unhealthy
obesity
(MUO)
can
affect
since
their
first
years
of
life,
and
novel
therapeutic
strategies
to
tackle
metabolic
complications
are
under
investigation.
This
review
focuses
bioactive
compounds
possible
beneficial
effects
obesity,
particularly
omega-3,
docosahexaenoic
acid,
vitamin
D,
biotics,
polysaccharide
macromolecules,
polyphenols,
inositols,
alpha
lipoic
bromelaine.
Our
aim
is
summarize
current
evidence
about
in
treatment
highlighting
recent
findings
use
adolescents.
Most
studied
molecules
omega-3
despite
heterogeneity
between
studies.
Moreover,
given
emerging
interest
gut-brain
axis
link
health
microbiota,
various
studies
prebiotics,
probiotics,
synbiotics,
postbiotics
macromolecules
have
been
considered.
Some
preclinical
seem
highlight
role
even
if
clinical
still
discussed.
Lastly,
we
describe
inositols
alpha-lipoic
acid.
Despite
some
dietary
supplements
be
promising
overweight
subjects,
only
few
them
dose/response
efficacy
has
found
pediatric
age.
Innovative,
well-designed
targeted
trials
then
needed
prove
these
that
could
support
standard
behavioral
therapy
for
obesity.
Critical Reviews in Food Science and Nutrition,
Год журнала:
2023,
Номер
64(22), С. 7707 - 7727
Опубликована: Март 27, 2023
Seaweed
polysaccharides
(SPs)
obtained
from
seaweeds
are
a
class
of
functional
prebiotics.
SPs
can
regulate
glucose
and
lipid
anomalies,
affect
appetite,
reduce
inflammation
oxidative
stress,
therefore
have
great
potential
for
managing
metabolic
syndrome
(MetS).
poorly
digested
by
the
human
gastrointestinal
tract
but
available
to
gut
microbiota
produce
metabolites
exert
series
positive
effects,
which
may
be
mechanism
render
their
anti-MetS
effects.
This
article
reviews
as
prebiotics
in
management
MetS-related
disturbances.
The
structure
studies
related
process
degradation
bacteria
therapeutic
effects
on
MetS
highlighted.
In
summary,
this
review
provides
new
perspectives
prevent
treat
MetS.